Spies, Marie
Murgaš, Matej http://orcid.org/0000-0001-7643-2182
Vraka, Chrysoula
Philippe, Cecile
Gryglewski, Gregor http://orcid.org/0000-0002-7344-8071
Nics, Lukas
Balber, Theresa
Baldinger-Melich, Pia http://orcid.org/0000-0001-8382-6665
Hartmann, Annette M.
Rujescu, Dan http://orcid.org/0000-0002-1432-313X
Hacker, Marcus
Winkler-Pjrek, Edda
Winkler, Dietmar http://orcid.org/0000-0001-8849-9907
Lanzenberger, Rupert http://orcid.org/0000-0003-4641-9539
Funding for this research was provided by:
Austrian Science Fund (P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141, P24359, P27141)
Article History
Received: 21 November 2022
Revised: 28 May 2023
Accepted: 1 June 2023
First Online: 15 June 2023
Conflict of interest
: MS has received travel grants from Janssen, Eli Lilly, and AOP Orphan Pharmaceuticals, lecture fees/author honoraria from Janssen, Austroplant, and Universimed, workshop participation from Eli Lilly, and is recipient of a NARSAD Young Investigator Grant. R. Lanzenberger received travel grants and/or conference speaker honoraria from Bruker BioSpin within the last three years and investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. DW has received lecture fees/authorship honoraria from Angelini, Lundbeck, Medical Dialogue, and MedMedia Verlag. MH received consulting fees and/or honoraria from Bayer Healthcare BMS, Eli Lilly, EZAG, GE Healthcare, Ipsen, ITM, Janssen, Roche, and Siemens Healthineers. All other authors declare no conflict of interest.